Recent Finacing
Recent Raise
Exeliom Biosciences is a Paris-based clinical-stage biotech developing NOD2-targeting microbiome immunotherapies for cancer, inflammatory diseases and chronic infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
